- Home
- DFS vs EW Comparison
DFS vs EW Comparison
Compare DFS & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFS
- EW
- Stock Information
- Founded
- DFS 1985
- EW 1958
- Country
- DFS United States
- EW United States
- Employees
- DFS N/A
- EW N/A
- Industry
- DFS Finance: Consumer Services
- EW Industrial Specialties
- Sector
- DFS Finance
- EW Health Care
- Exchange
- DFS Nasdaq
- EW Nasdaq
- Market Cap
- DFS 37.0B
- EW 42.5B
- IPO Year
- DFS 2007
- EW 2000
- Fundamental
- Price
- DFS $173.05
- EW $74.78
- Analyst Decision
- DFS Buy
- EW Buy
- Analyst Count
- DFS 18
- EW 21
- Target Price
- DFS $148.60
- EW $79.40
- AVG Volume (30 Days)
- DFS 1.4M
- EW 5.6M
- Earning Date
- DFS 01-15-2025
- EW 02-04-2025
- Dividend Yield
- DFS 1.62%
- EW N/A
- EPS Growth
- DFS N/A
- EW 193.69
- EPS
- DFS 12.39
- EW 6.89
- Revenue
- DFS $11,686,000,000.00
- EW $6,314,900,000.00
- Revenue This Year
- DFS N/A
- EW N/A
- Revenue Next Year
- DFS N/A
- EW $0.91
- P/E Ratio
- DFS $13.98
- EW $28.85
- Revenue Growth
- DFS 11.97
- EW 24.02
- 52 Week Low
- DFS $96.46
- EW $58.93
- 52 Week High
- DFS $188.26
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- DFS 50.14
- EW 62.35
- Support Level
- DFS $167.30
- EW $72.29
- Resistance Level
- DFS $179.08
- EW $74.58
- Average True Range (ATR)
- DFS 3.97
- EW 1.93
- MACD
- DFS -1.75
- EW 0.06
- Stochastic Oscillator
- DFS 43.33
- EW 91.36
About DFS Discover Financial Services
Discover Financial Services is a bank operating in two distinct segments: direct banking and payment services. The company issues credit and debit cards and provides other consumer banking products including deposit accounts and personal loans. It also operates the Discover, Pulse, and Diners Club networks. The Discover network is the fourth-largest payment network in the United States as ranked by overall purchase volume, and Pulse is one of the largest ATM networks in the country.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.